RPS6P3

Across TCGA pan-cancer cohorts, RPS6P3 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPS6P3’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RPS6P3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS6P3 is over-expressed in tumor, although a few such as BRCA and STAD show the opposite, repressed pattern.

LUAD, BRCA, and STAD are the cancer types where RPS6P3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS6P3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.031	.022	2	view →
BRCA	Female	All	−0.020	.020	2	view →
STAD	Male	All	−0.038	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPS6P3–LUAD

Open the LUAD breakdown →